Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine for Cognitive Function in Schizophrenia
NCT00420498Phase 2Completed
- Sponsor
- Yale University
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atomoxetine in schizophrenia, sponsored by Yale University. Started Aug 2005; status: completed.
02
Drugs
atomoxetine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00420498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00420498.